Pfizer Inc. remains a Strong Buy, offering compelling value with a 6.32% dividend yield and a P/E Non-GAAP of 8.43. Learn ...

For income investors, there are numerous dividend stocks with strong records, stability and growth potential that can generate wealth for you in the long term.

What does a successful retirement look like? If it means financial security through steady income sources, then you can get there with the help of high-yield dividend stocks. Since retirement is ...

Among U.S.-listed healthcare stocks with market caps of at least $200 million, the three highest-yielding are Perrigo ( PRGO ...

Nurse practitioner Nikki Shaffer, a senior director of Global Colleague Wellness at Pfizer, joins "CBS Mornings" to mark ...

Pfizer CEO Albert Bourla said the company was on track with new products, but shares fell as it signaled lower revenues in 2026 ...

Shares of pharmaceutical giant Pfizer (NYSE: PFE) have been crashing for multiple years. The last time it posted a positive ...

Nearly three months after winning a contentious bid to buy obesity drugmaker Metsera Inc. for $10 billion, Pfizer Inc. reported its first statistically significant data of the acquired lead, ...

Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its modest 2026 guidance that rattled investors in December ...

“Pfizer appears cheap with a near 7% yield, but capital allocation constraints undermine its investment case. Nearly all of PFE's free cash flow is consumed by dividends, leaving little for buybacks, ...

Pfizer is playing catch-up in the GLP-1 weight-loss space. The drugmaker is getting closer and closer to key patent cliffs. Investors should also note that Pfizer's payout ratio is worryingly high.